Novo Nordisk CEO on his legacy: What I spend most of my time on

The man in charge of Novo Nordisk, Lars Fruergaard Jørgensen, spends most of his time securing the future growth of the company – and the legacy he will one day pass on. The CEO thinks golden opportunities are in the making.

Novo Nordisk President & CEO Lars Fruergaard Jørgensen. | Photo: Stine Bidstrup/ERH

The turn of the year marked Lars Fruergaard Jørgensen's fourth year in charge of Novo Nordisk, and even though the 54-year-old president and CEO has no plans to leave his post any time soon, a lot of his energy goes into cementing the legacy which he will one day pass on to his successor.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs